Radcliffe Capital Management, L.P. - ORION BIOTECH OPPORTUNTES CO ownership

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$5,200
-99.4%
80,0010.0%0.00%
-100.0%
Q4 2022$804,010
+2.0%
80,0010.0%0.02%
+31.6%
Q3 2022$788,000
+1.2%
80,0010.0%0.02%
+5.6%
Q2 2022$779,0000.0%80,001
+0.0%
0.02%0.0%
Q1 2022$779,000
-0.1%
80,0000.0%0.02%
-10.0%
Q4 2021$780,000
-0.3%
80,0000.0%0.02%
-13.0%
Q3 2021$782,00080,0000.02%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q3 2023
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 60,000$603,0000.11%
GRITSTONE ASSET MANAGEMENT LLC 276,000$41,8690.05%
Anson Funds Management LP 15,000$150,7500.02%
Radcliffe Capital Management, L.P. 80,001$804,0100.02%
Segantii Capital Management Ltd 30,000$302,0000.01%
Arena Capital Advisors, LLC- CA 111,314$16,8860.01%
PERISCOPE CAPITAL INC. 383,533$58,9420.00%
683 Capital Management, LLC 239,800$36,3780.00%
Atalaya Capital Management LP 100,000$15,0000.00%
Kepos Capital LP 80,000$120.00%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders